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Abstract
Introduction: Preoperative scores are widely used predictors 
of complications after major surgery. These scores, however, 
are not widely used in transurethral procedures. The aim of this 
study was to assess the value of the Charlson Comorbidity 
Index (CCI), the age-adjusted CCI, the American Society of 
Anesthesiologist score (ASA) and the Nutritional Risk Score 
(NRS) in predicting early mor-bidity after transurethral 
urological procedures.
Methods: Consecutive patients undergoing transurethral 
resection of the bladder or the prostate were prospectively 
enrolled. The scores were calculated preoperatively; 30-day 
complications were prospectively recorded according to the 
Dindo-Clavien classifica-tion. Univariate logistic regression 
was performed to investigate the value of each score and of 
other factors (i.e., age, sex, body mass index, anemia, smoking 
habit, type of operation and anaesthesia) as predictors of 
complications. A multivariate model was then calculated 
using these predictors.
Results: Overall, 197 patients were included. The mean age 
was 72 (standard deviation ± 10). In total, 26.9% patients had 
at least 1 complication. Using univariate analysis, we found 
that each score significantly predicted complications. In 
multivariate analysis, only the ASA (odds ration [OR] 2.11; 
95% confidence interval [CI] 1.01-4.43) and the NRS (OR 
2.42; 95% CI 1.56-3.74) remained independent predictors. 
The best model incorporated ASA, NRS and gender, and 
predicted morbidity with an area under the curve of 76%. Our 
study’s main limitations are population heterogeneity and 
limited sample size.
Conclusion: The ASA and the NRS are important and 
independent determinants of early morbidity after transurethral 
procedures. The use of these indices may assist clinicians in 
the decision-making process to balance the possible benefits 
of transurethral procedures with the potential risks.
Introduction 
Transurethral resection of the bladder (TURB) and of the 
prostate (TURP) are key operations in the management of 
bladder tumours and benign prostatic hyperplasia (BPH), 
respectively. TURB is the cornerstone for initial diagnosis 
and risk stratification of suspicious bladder lesions, and is 
the first-line treatment for non-muscle invasive urothelial 
cancer.1 TURP is the gold standard for men with moder-
ate-to-severe bladder outlet obstruction due to BPH, and 
for patients with milder symptoms who do not respond to 
oral treatment.2 The increased life expectancy in developed 
countries and the subsequent increase in incidence of both 
diseases have contributed to increased frequency of TURB 
and TURP. However, a parallel process with aging is the 
increased prevalence of severe comorbidity.  
In an attempt to improve patient’s selection, taking into 
account benefits and risks, various preoperative indices 
have been developed. The most common scores are the 
Charlson Comorbidity Index (CCI), the age-adjusted CCI and 
the American Society of Anesthesiologist score (ASA). Their 
value has been tested in some urological procedures with 
moderate to high perioperative risk.3-5 The significance of 
their association, not only with the perioperative morbidity 
but also with survival, has led to the integration of these 
scores in nomograms to predict mortality after certain pro-
cedures.6 Another preoperative score, the Nutritional Risk 
Score (NRS), has been associated with perioperative risk in 
gastrointestinal surgery, and might be also useful in urologi-
cal surgery.7,8 
Despite the theoretical usefulness of these scores in 
patients undergoing surgery, their use is very limited in uro-
logical procedures with expected low postoperative morbid-
ity, like transurethral resections. Particularly, the additional 
value of the NRS in this population has never been tested. 
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The aim of this study was to assess the impact of the CCI, the 
ACCI, the ASA and the NRS on early postoperative morbidity 
after TURB and TURP.
Methods
Overview
This prospective study was approved by the local Ethics 
Committee (Protocol number 34/11); the results are 
reported according to the Strengthening the Reporting of 
Observational Studies in Epidemiology (STROBE) statement 
on observational studies.9 This study was conducted at our 
tertiary university hospital from June 2011 to June 2012. 
Consecutive patients undergoing elective TURB or TURP 
were invited to participate. After signing a specific consent 
form, patients were included, unless the procedure had 
been anticipated or postponed due to an urgent reason. 
The procedures were performed by last-year trainees or by 
consultants. The normal perioperative course at our hospital 
for transurethral resections consists of an overall hospital 
stay of 4 days, including admission day, procedure day fol-
lowed by 24-hour continuous bladder washing, trial without 
catheter and discharge. 
Comorbidity, anesthesiology and nutritional scores 
The 4 scores tested in this study were: the CCI, the age-
adjusted CCI, the ASA and the NRS. The CCI was calculated 
by the operating urologist; the age-adjusted CCI was derived 
from the CCI by age-adjustment; the ASA was assessed by the 
anesthesiologist responsible for patient perioperative care; 
and the NRS was calculated by a clinical research nurse 
with specific training in malnutrition assessment (Table 1). 
For the purpose of the analyses and based on the litera-
ture, all indices were dichotomized as follows: CCI 0 versus 
≥1; age-adjusted CCI 0 to 5 versus ≥6; ASA 1 to 2 versus 3 to 
4; NRS 0 to 2 versus ≥3.3,10,11 Similarly, potential confounders 
were dichotomized as follows: age (<70 vs. ≥70), gender, 
smoking (yes vs. no), type of resection (TURB vs. TURP), 
type of anesthesia (spinal vs. general), body mass index (BMI, 
<18.5 vs. ≥18.5), and anemia (cutoff heamatocrit value at 
35% and 40% for women and men, respectively). 
Assessment of complications 
Complications were classified by type, and graded using 
the Dindo-Clavien classification adjusted for transurethral 
procedures.12 Based on the treatment undertaken to manage 
1 complication, the Dindo-Clavien classification uses the 
severity of the complication.13
In the final analysis, if 1 patient had more than 1 compli-
cation, only the most severe complication was considered. 
In-hospital complications were recorded and graded by a 
dedicated research nurse under the supervision of the study 
team. Also, complications were recorded at the first follow-
up visit at 30 days.
In all patients, source data verification of all data entered, 
including the calculation of the CCI and the age-adjusted 
CCI, was performed by a clinical research nurse to verify the 
completeness and validity of the case report form.
Statistical analysis 
Continuous variables are reported by mean ± standard 
deviation (SD), or by median and interquartile range (IQR) 
according to their distribution. Categorical variables were 
given using frequencies and proportions. To examine the 
impact of preoperative indices and possible confounders on 
complications, we performed univariate logistic regression. 
Multivariate logistic regression was performed to determine 
the best model using the different indices alone, or com-
bined with the other predictors. A stepwise selection proce-
dure was used.14 Odds ratio (OR) for univariate analysis and 
adjusted OR for multivariate analysis with their associated 
95% confidence interval (95% CI) were reported for each 
explanatory variable. All statistical tests were analyzed by a 
statistician using Stata (Stata Statistical Software: Release 12, 
College Station, TX). P values less than 0.05 were considered 
statistically significant. 
Results 
In the study period, 55 patients were excluded, either 
because they did not meet the inclusion criteria (n = 36), 
because of incomplete preoperative data (n = 11) or because 
they did not attend the first postoperative visit at 1 month at 
our institution (n = 8). Overall, 197 patients were included 
in the final analysis (Table 2). 
Table 1. Calculating the Nutritional Risk Score (NRS)
Nutritional status Disease/surgery severity Age
0 Normal Normal <70
1
Weight loss >5%/3 months 
or 
Food intake <75%
Includes chronic disease, 
hip fracture, cancer, 
minor surgery
≥70
2
Weight loss >5%/2 months 
or 
Food intake <50% or 
BMI 18.5-20.5
Includes major surgery, 
myocardial infarction, 
pneumonia, lymphoma, 
leukemia
3
Weight loss >5%/1 month 
(or >15%/3 months) or
Food intake <25% or
BMI <18.5
Includes head trauma, 
transplantation, intensive 
care patients
BMI: body mass index. The Nutritional Risk Score (NRS) is calculated by adding 3 different 
components: nutritional status + disease/surgery severity + age. Only the more severe 
contribution to the overall score of each of these 3 elements is considered in the overall 
score.
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The mean patient age was 72 (SD ± 10); 158 (80.2%) 
patients were men. The CCI identified more patients with 
comorbidities as compared to the age-adjusted CCI and to 
the ASA score (68% vs. 36% vs. 30%, respectively). Using 
the NRS, 17.3% of the patients were considered at nutri-
tional risk.
Within the study period, 53 patients (26.9%) had at least 
1 complication (Table 3). Among these complications, 13 
were classified as grade I, 32 as grade II, 4 as grade IIIb, 1 
as grade IVa, 1 as grade IVb, and 2 patients died (grade V). 
Moreover, 8 of these patients had a secondary complica-
tion, and 1 had 2 additional complications. All secondary 
and tertiary complications were grade I (n = 3) or II (n = 7).
All the comorbidity and nutritional indices were signifi-
cant predictors of complication on univariate analysis: NRS 
(OR 4.25), ASA (OR 3.20), CCI (OR 1.23) and age-adjusted 
CCI (OR 1.22). Further, men (OR 3.65), patients over 70 
(OR 2.58) and with anemia (OR 3.81) were more prone 
to complications. In contrast, the type of operation and of 
anesthesia, the smoking status and the BMI did not affect 
postoperative morbidity (Table 4).
After multivariate analysis, the NRS and the ASA remained 
the only statistically significant predictors of postoperative 
complications, with an OR at 2.42 and 2.11, respectively 
(Table 5). Among the other factors, being male was the 
only substantial predictor of early postoperative morbid-
ity in multivariate analysis (OR 4.37). The best predictive 
model combined the NRS, the ASA and gender, and had a 
sensitivity of 63%, a specificity of 79% and an area under 
the curve of 76%. 
Discussion 
This study shows that the NRS may be the best preoperative 
score to predict early morbidity after TURB and TURP. Based 
on this study, while the ASA has also a significant value in 
stratifying patients at risk, the CCI and the age-adjusted CCI 
did not add substantial value to the other indices. This is a 
surprising result as the ASA, the CCI and the age-adjusted 
CCI are widely used tools before surgical procedures across 
different specialties, whereas the NRS is poorly used in urol-
ogy, and no study has previously assessed its predictive 
value in patients undergoing TURB or TURP.
The CCI has been validated in predicting mortality after 
TURP. In a large cohort of 7632 men, a nomogram, based 
on the CCI and age, was able to predict early mortality with 
an accuracy of 83% in the validation cohort.15 In terms of 
morbidity, another study showed a significant association 
between complications after TURP and CCI.16 While the 
association between survival and comorbidity status could 
Table 2. Descriptive characteristics of the study population
Variable Study population
Age 72 (±10)
Sex
Male 158 (80.2%)
Female 39 (19.8%)
BMI 27 kg/m2 (24.3 - 29.4)
Anemia
No 146 (74.1%)
Yes 51 (25.9%)
Smoking habit
No 117 (59.4%)
Yes 80 (40.6%)
Anesthesia
General 76 (38.6%)
Spinal 121 (71.4%)
Operation
TURB 124 (72.9%)
TURP 73 (37.1%)
ASA
I 12 (6%)
II 126 (64%)
III 59 (30%)
IV 0
CCI
0 63 (32%)
≥1 134 (68%)
Age-adjusted CCI
0–5 126 (64%)
≥6 71 (36%)
NRS
1–2 163 (82.7%)
≥3 34 (17.3%)
BMI: body mass index; TURB: transurethral resection of the bladder; TURP: transurethral 
resection of the prostate; ASA: American Society of Anesthesiologists; CCI: Charlson 
Comorbidity Index; NRS: Nutritional Risk Score. Continuous variables are displayed by 
mean (± standard deviation), or by median (interquartile range); categorical variables are 
displayed by frequencies (proportions).
Table 3. The complications occurred in the study 
population are displayed per type
Type of complication No. patients, %
Delayed length of hospital stay 18 (9.2%)
Hematuria 13 (6.6%)
Urinary tract infection 6 (3.1%)
Acute urinary retention 5 (2.5%)
Blood clot retention 3 (1.5%)
Organ perforation 3 (1.5%)
Deep vein thrombosis 1 (0.5%)
Renal failure 1 (0.5%)
Sepsis 1 (0.5%)
Myocardial infarction (Death) 1 (0.5%)
Pulmonary embolism (Death) 1 (0.5%)
Total 53 (26.9%)
Based on the outcome measure, which was the Dindo-Clavien classification, the same type 
of complication can be scored with different grades according to how it was managed.
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not be evaluated in our study given the limited sample size 
and the short follow-up, the value of the CCI in predict-
ing morbidity was verified only in the univariate analysis. 
Although this might also be related to a small number of 
patients, it is important to highlight that other preoperative 
indices, such as the ASA and the NRS, were significantly 
associated with postoperative morbidity.
The role of the other scores used in this study has been 
poorly assessed in patients undergoing transurethral resec-
tions. In our study, the same comments regarding the CCI 
might also be applied to the age-adjusted CCI since the 2 
scores are closely related, the latter representing an adjust-
ment of the CCI based on age. In contrast, the ASA con-
firmed its value in the present study. The paucity of the 
reports investigating this score after transurethral procedures 
may be because the ASA is already widely used in clinical 
practice by anesthesiologists.17 
The most interesting finding of this study is the substan-
tial utility of the NRS in predicting early morbidity after 
transurethral operations. Although the NRS is a composite 
score, including age and disease severity, the multivariate 
analysis suggests that nutritional status is the key feature of 
this score. Malnutrition is a strong predictor of morbidity 
and mortality after gastrointestinal surgery, and its preva-
lence among patients undergoing other procedures might be 
underestimated.18 In fact, the consequences of malnutrition 
on the surgical outcome are related to the so-called “surgical 
stress,” rather than the effects of specific procedures on the 
organism; therefore, malnutrition is likely to play an essential 
negative role in most of the surgical patients.19 
In our study, only 17.3% of patients were considered at 
nutritional risk. This rate is significantly less than the rate 
of patients at risk of complications identified by the other 
scores, which ranged from 30% to 68%. This wide differ-
ence is possibly related to the outcome measure we used to 
identify patients at nutritional risk (the NRS). Indeed, while 
the CCI, the age-adjusted CCI and the ASA consider only 
the comorbidity status before treatment to determine the 
impact of coexisting diseases on surgical outcome, the NRS 
aims to identify patients at risk by combining 3 different 
components: nutritional status, severity of the surgery and 
age. In other words, in contrast to the other scores, the NRS 
is probably more selective since it considers a number of 
factors that seem to contribute to the “surgical stress.”11 
While this observational study has high internal validity 
and adheres to the STROBE guidelines for reporting obser-
vational studies, it has some limitations. The complications 
were evaluated only in the 30 days after the procedure. As 
a consequence, late complications after transurethral resec-
tions were not taken into account. In addition, it can be 
argued that including patients undergoing TURB for blad-
der cancer with men undergoing TURP for BPH can lead 
to heterogeneity bias. Although we agree that this bias is 
possible, we also believe that these procedures have many 
similarities regarding the endoscopic approach and the type 
of early complications; thus, the systematic error related 
to this heterogeneity should be minimal. This argument is 
also sustained by the fact that the operation type was not a 
predictor of morbidity either in the univariate or in the mul-
tivariate analysis. Moreover, all indices were dichotomized 
given the limited sample size that would have required a 
very large effect if each score was treated as a continuous 
or a categorical variable. This approach may have underes-
timated the predictive ability of indices with a wide range of 
possible values (namely the CCI and the age-adjusted CCI). 
Further, no power calculation was performed prior to the 
study. This was due to a lack of similar studies exploring the 
Table 4. Univariate analysis of predictors of complications
Variable OR (95% CI) p value
Age 2.58 (1.26-5-27) 0.009
Sex 3.65 (1.22-10.86) 0.020
BMI 1.00 (0.93-1.08) 0.971
Anaemia 3.81 (1.84-7.91) 0.000
Smoking habit 0.80 (0.41-1.57) 0.521
Anesthesia 0.90 (0.46-1.76) 0.763
Type of operation 1.72 (0.89-3.33) 0.110
ASA 3.2 (1.62-6.33) 0.001
CCI 1.23 (1.07-1.42) 0.004
Age-adjusted CCI 1.22 (1.09-1.38) 0.001
NRS 4.25 (2.25-10.91) 0.000
OR: odds ratio; CI: confidence interval; BMI: body mass index; ASA: American Society of 
Anesthesiologists; CCI: Charlson Comorbidity Index; NRS: Nutritional Risk Score.
Table 5. Multivariate logistic regression using a stepwise 
selection to determine the best model to predict 
complications
Variable OR (95% CI) p value
Age NS
Sex 4.37 (1.27-10.08) 0.020
BMI NS
Anemia NS
Smoking Habit NS
Anaesthesia NS
Type of operation NS
ASA 2.11 (1.01-4.43) 0.048
CCI NS
Age-adjusted CCI NS
NRS 2.42 (1.56-3.74) 0.000
Area under the curve 76%
Sensitivity 63%
Specificity 79%
Positive predictive value 51%
Negative predictive value 86%
NS: not significant; OR: odds ratio; CI: confidence interval; BMI: body mass index; ASA: 
American Society of Anesthesiologists; CCI: Charlson Comorbidity Index; NRS: Nutritional 
Risk Score.
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value of these scores in this population. Finally, the predic-
tive model was not validated, and should be additionally 
tested to demonstrate the results achieved in this study. 
Despite these limitations, we believe that this study 
has worthy clinical implications and should guide future 
research. Based on our study, we feel that the use of NRS 
should be implemented in clinical practice since it was 
the single most significant predictor of complications. 
Considering the combined value of the nutritional status, 
the severity of surgery and age, the NRS appears to reflect 
at best the perioperative risk of surgical patients, even in 
minor surgery. Further, the NRS has attractive advantages 
over other indices. Indeed, it is validated and easily used by 
non-medical staff members, it correlates to biological mea-
sures of malnutrition, has no cost implications, and could 
be used to select patients who might benefit from nutritional 
support.11 Finally, with a specificity of 79% and a negative 
predictive value of 86%, the best model to predict compli-
cations could assist clinicians to balance risk and benefit in 
the decision-making process. Still, this model has yet to be 
validated in external cohorts. 
Conclusion 
The importance of preoperative scores as predictors of early 
complications is applicable also to patients undergoing 
TURB or TURP. Particularly, the use of a simple nutritional 
score, the NRS, may be helpful to clinicians in the preop-
erative assessment.
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